Free Trial
→ JD Vance Predicts: Wall Street vs. Trump & Your Money (From Priority Gold) (Ad) Free ELEV Stock Alerts

Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts

Elevation Oncology logo
$0.58 0.00 (0.00%)
(As of 11/20/2024 ET)
Compare

Elevation Oncology Latest Earnings Summary

Upcoming
Earnings Date
Mar. 5Estimated
Actual EPS
(Nov. 6)
-$0.22 Missed By -$0.02
Consensus EPS
(Nov. 6)
-$0.20

Elevation Oncology posted Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.22, which missed analysts' consensus estimates of -$0.20 by $0.02. With a trailing EPS of -$0.82, Elevation Oncology's earnings are expected to decrease next year, from ($0.84) to ($0.89) per share.

ELEV Upcoming Earnings

Elevation Oncology's next earnings date is estimated for Wednesday, March 5, 2025, based off prior year's reporting schedules.

Get Elevation Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevation Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ELEV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELEV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevation Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243-$0.23-$0.19-$0.21
Q2 20243-$0.26-$0.20-$0.22
Q3 20243-$0.21-$0.20-$0.21
Q4 20243-$0.24-$0.23-$0.23
FY 202412-$0.94-$0.82-$0.87
Q1 20252-$0.27-$0.23-$0.25
Q2 20252-$0.29-$0.23-$0.26
Q3 20252-$0.24-$0.19-$0.22
Q4 20252-$0.24-$0.20-$0.22
FY 20258($1.04)($0.85)($0.95)

Elevation Oncology Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/5/2025
(Estimated)		------- 
11/6/2024--$0.20-$0.22 -$0.02-$0.22--
8/6/2024--$0.23-$0.18+$0.05-$0.18--  
5/2/2024Q1 2024-$0.21-$0.23 -$0.02-$0.23--  
3/6/2024Q4 2023-$0.21-$0.19+$0.02-$0.19--  
11/2/2023Q3 2023-$0.34-$0.25+$0.09-$0.25--
8/3/2023Q2 2023-$0.28-$0.37 -$0.09-$0.37--  
5/15/2023Q1 2023-$0.51-$0.50+$0.01-$0.28--  
3/9/2023Q4 2022-$0.67-$4.09 -$3.42-$4.09--  

Elevation Oncology Earnings - Frequently Asked Questions

Elevation Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates. Learn more on ELEV's earnings history.

In the previous quarter, Elevation Oncology (NASDAQ:ELEV) missed the analysts' consensus estimate of ($0.20) by $0.02 with a reported earnings per share (EPS) of ($0.22). Learn more on analysts' earnings estimate vs. ELEV's actual earnings.

Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$45.70 million. ELEV has generated -$0.82 earnings per share over the last four quarters.

Elevation Oncology's earnings are expected to decrease from ($0.84) per share to ($0.89) per share in the next year.

`

More Earnings Resources from MarketBeat

Related Companies
Earnings Tools
Earnings By Country
Latest Articles


This page (NASDAQ:ELEV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored